Article
Tissue microarrays in cancer diagnosis
1 Jul 2003
Abstract excerpt
New molecular techniques such as cDNA, protein or antibody arrays allow for high-throughput identification of thousands of potentially disease-related markers on the genome, transcriptome and proteome level. Major disadvantages of such studies are the enormous costs and the need for unfixed tissues, disallowing comprehensive large-scale studies. Consequently, validation studies including large sets of clinically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
